Gene Analysis for Bone and Soft Tissue Tumors

  • Nobuhito Araki
  • Atsumasa Uchida
  • Tomoatsu Kimura
  • Hideki Yoshikawa
  • Yasuaki Aoki
  • Takafumi Ueda
  • Keiro Ono
Conference paper


It is generally accepted that malignant tumors arise from some genetic disorders which lead to abnormal proliferation and differentiation of the tumor cells. Moreover, some disorders may modulate the malignant properties, such as invasiveness or metastatic potential. Recent advances in molecular biology revealed these characteristic gene abnormalities in many cancers, and they have been classified as oncogenes, anti-oncogenes and modulator genes [1]. An oncogene usually codes some growth regulatory sequence, such as growth factor or its receptor, and controls tumor development positively. On the other hand, an anti-oncogene regulates the tumor cell negatively, normally suppressing tumorigenicity. Inactivation of the anti-oncogene will cause a tumor. Modulator genes are defined as the genes which can influence secondary malignant properties as, for example, in multidrug-resistant genes [2]. Analyses of these disordered genes in various tumors will offer a useful diagnostic tool to understand the characteristic behavior of the tumor and to decide upon appropriate therapy, because they reflect the essential properties of the disease. There is also a possibility that a new diagnostic classification can be made by adding the genetic information to the ordinary pathological classification. However, in bone and soft tissue, these analyses have just begun in only a few kinds of tumors. We report the involvement of c-fos gene expression as an oncogene and Rb (retinoblastoma) gene disorders as an anti-oncogene in some bone and soft tissue tumors.


Synovial Sarcoma Soft Tissue Tumor Malignant Fibrous Histiocytoma Giant Cell Tumor Heterozygous Deletion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Klein G (1987) The approaching era of the tumor suppressor genes. Science 238: 1539–1545PubMedCrossRefGoogle Scholar
  2. 2.
    Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistant gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265–269PubMedCrossRefGoogle Scholar
  3. 3.
    Friend SH, Bernards R, Rogeli S, Weinberg RA, Rapaport JM, Albert DM, Drija TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643–646PubMedCrossRefGoogle Scholar
  4. 4.
    Abramson DH, Ellsworth RM, Kitchin FD, Tung G (1984) Second nonocular tumors in retinoblastoma survivors. Ophthalmology 91: 1351–1355PubMedCrossRefGoogle Scholar
  5. 5.
    Araki N, Uchida A, Kimura T, Yoshikawa H, Aoki Y, Ueda T, Takai S, Miki T, Ono K (1991) Involvement of the retinoblastoma gene in primary osteosarcoma and other bone and soft-tissue tumors. Clin Orthop 270: 271–277PubMedGoogle Scholar
  6. 6.
    Finkel MP, Biskis BO, Jinkins PB (1966) Virus induction of osteosarcoma in mice. Science 151: 698–701PubMedCrossRefGoogle Scholar
  7. 7.
    Curran T, Macconnell WP, Straaten FV, Verma IM (1983) Structure of the FBJ murine osteosarcoma virus genome: Molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells. Mol Cell Biol 3: 914–921PubMedGoogle Scholar
  8. 8.
    Rüther U, Garber C, Komitowski D, Muller R, Wagner EF (1987) Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325: 412–416PubMedCrossRefGoogle Scholar
  9. 9.
    Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, New YorkGoogle Scholar
  10. 10.
    Fung YKT, Murphree AL, T’Ang A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657–1661PubMedCrossRefGoogle Scholar
  11. 11.
    Lee WH, Bookstein R, Hong F, Young LJ, Lee EYHP (1987) Human retino-blastoma susceptibility gene: Cloning, identification, and sequence. Science 235: 1394–1399Google Scholar
  12. 12.
    Toguchida T, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T (1988) Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48: 3939–3943PubMedGoogle Scholar
  13. 13.
    Huang HJS, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EYHP, Lee WH (1988) Suppression of the neoplastic phenotype by replacement of the Rb gene in human cancer cells. Science 242: 1563–1566PubMedCrossRefGoogle Scholar
  14. 14.
    Wunder J, Bell RS, Czitrom A, Andrulis I (1991) MDR1 expression and clinical outcome in osteosarcoma: A pilot study. ORS Transaction, 37th 16: 264Google Scholar
  15. 15.
    Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B, Koeffler P (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50: 7950–7954PubMedGoogle Scholar

Copyright information

© Springer Japan 1992

Authors and Affiliations

  • Nobuhito Araki
  • Atsumasa Uchida
  • Tomoatsu Kimura
  • Hideki Yoshikawa
  • Yasuaki Aoki
  • Takafumi Ueda
  • Keiro Ono
    • 1
  1. 1.Department of Orthopaedic SurgeryOsaka University Medical SchoolOsaka, 553Japan

Personalised recommendations